2-(tert-butyl)-6-bromoquinoline | 1394819-76-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 2-(tert-butyl)-6-bromoquinoline
• 英文别名: 6-bromo-2-(tert-butyl)quinoline；6-bromo-2-tert-butylquinoline
• CAS: 1394819-76-1
• 化学式: C₁₃H₁₄BrN
• 分子量: 264.165
• InChiKey: YTMCRXBFQKLJPH-UHFFFAOYSA-N

物化性质

• 沸点：
  322.9±22.0 °C(Predicted)
• 密度：
  1.323±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.31
• 拓扑面积：
  12.9
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-(tert-butyl)-6-bromoquinoline 在 正丁基锂 、 溶剂黄146 作用下， 以 四氢呋喃 、 甲醇 、 正己烷 、 水 为溶剂， 反应 1.58h， 生成 (E)-3-(2-tert-butylquinoline-6-sulfonyl)acrylonitrile
  参考文献：
  名称：

  Design, Synthesis, and Biological Evaluation of Sulfonyl Acrylonitriles as Novel Inhibitors of Cancer Metastasis and Spread

  摘要：

  The spread of intra-abdominal cancers is a vexing clinical problem for which there is no widely effective treatment. We discovered previously that (2E)-3-[(4-tert-butylphenyl)sulfonyl]acrylonitrile (1) induced cancer cell apoptosis during adhesion to normal mesothelial cells which line the peritoneum. We recently demonstrated that the sulfonylacrylonitrile portion of 1 and hydrophobic aryl substitution were essential for pro-apoptotic activity in cancer cells. Here we synthesized a diverse series of analogues of 1 in order to improve the efficacy and pharmaceutical properties. Analogues and 1 were compared in their ability to cause cancer cell death during adhesion to normal mesothelial cell monolayers. Potent analogues identified in the in vitro assay were validated and found to exhibit improved inhibition of intra-abdominal cancer in two clinically relevant murine models of ovarian and pancreatic cancer spread and metastasis, highlighting their potential clinical use as an adjunct to surgical resection of cancers.

  DOI：

  10.1021/jm501437v
• 作为产物：
  描述：

  频哪酮 、 2-氨基-5-溴苯甲醛 在 potassium hydroxide 作用下， 以 水 为溶剂， 反应 3.0h， 以64%的产率得到2-(tert-butyl)-6-bromoquinoline
  参考文献：
  名称：

  [EN] VINYL -ARYL - SULFONES FOR USE IN PERITONEAL CARCINOMATOSIS
  [FR] COMPOSÉS SOUFRÉS AROMATIQUES SUBSTITUÉS ET PROCÉDÉS DE LEUR UTILISATION

  摘要：

  公开号：

  WO2012116151A3

文献信息

• QUINUCLIDINE COMPOUNDS AS ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
  申请人：Cook, II James H.

  公开号：US20090270405A1

  公开（公告）日：2009-10-29

  The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands for the nicotinic α7 receptor and may be useful for the treatment of various disorders of the central nervous system, especially affective and neurodegenerative disorders.

  该披露提供了公式I的化合物，包括它们的盐，以及使用这些化合物的组合物和方法。这些化合物是烟碱性α7受体的配体，可能对治疗中枢神经系统的各种疾病，特别是情感和神经退行性疾病，有用。
• Visible Light-Mediated Decarboxylative Alkylation of Pharmaceutically Relevant Heterocycles
  作者：Alexandra C. Sun、Edward J. McClain、Joel W. Beatty、Corey R. J. Stephenson

  DOI：10.1021/acs.orglett.8b01250

  日期：2018.6.15

  A net redox-neutral method for the decarboxylative alkylation of heteroarenes using photoredox catalysis is reported. Additionally, this method features the use of simple, commercially available carboxylic acid derivatives as alkylating agents, enabling the facile alkylation of a variety of biologically relevant heterocyclic scaffolds under mild conditions.

  报道了使用光氧化还原催化的杂芳烃的脱羧烷基化的净氧化还原中性方法。另外，该方法的特征在于使用简单的可商购的羧酸衍生物作为烷基化剂，从而能够在温和条件下容易地将多种生物学上相关的杂环支架烷基化。
• Visible-light-mediated photoredox decarbonylative Minisci-type alkylation with aldehydes under ambient air conditions
  作者：Zhongzhen Wang、Xiaochen Ji、Jinwu Zhao、Huawen Huang

  DOI：10.1039/c9gc03008e

  日期：——

  Photocatalytic aerobic decarbonylative C–C coupling/alkylations of N-heteroarenes with aldehydes have been disclosed for the first time.

  首次披露了N-杂环烃与醛的光催化空气氧化脱羰基C-C偶联/烷基化反应。
• Regiodivergent C–H Alkylation of Quinolines with Alkenes by Half-Sandwich Rare-Earth Catalysts
  作者：Shao-Jie Lou、Liang Zhang、Yong Luo、Masayoshi Nishiura、Gen Luo、Yi Luo、Zhaomin Hou

  DOI：10.1021/jacs.0c08362

  日期：2020.10.21

  quinolines with styrenes and that of a C5Me4H-ligated yttrium catalyst Y-2 for the reaction with aliphatic olefins exclusively afforded the corresponding C8-H alkylation products, thus constituting the first example of direct C8‒H alkylation of neutral quinolines. In contrast, the Sc-3-catalyzed reaction of 2-aryl quinolines with aliphatic olefins and the Y-2-catalyzed reaction with styrenes selective-ly

  烯烃对 CH 烷基化的区域发散催化具有极大的兴趣和重要性，但迄今为止几乎没有探索过。我们在此报告了通过半夹心稀土催化剂对喹啉与烯烃的首次区域发散 CH 烷基化。区域发散是通过微调催化剂的金属/配体组合或空间和电子特性来实现的。使用 C5Me5 连接的钪催化剂 Sc-3 用于喹啉与苯乙烯的反应和使用 C5Me4H 连接的钇催化剂 Y-2 用于与脂肪族烯烃的反应仅提供相应的 C8-H 烷基化产物，从而构成中性喹啉直接 C8-H 烷基化的第一个例子。相比之下，Sc-3-催化2-芳基喹啉与脂肪族烯烃的反应和Y-2-催化与苯乙烯的反应选择性地得到2-芳基邻-C-H烷基化产物。基于催化剂/底物控制的区域发散，还实现了喹啉与两种不同烯烃的顺序区域特异性二烷基化。DFT 研究表明 2-苯基喹啉在 2-苯基取代基的 C8 位和邻位的 C-H 活化是可能的，并且这两种最初形成的 C-H 活化产物可以通过配位相互转化和
• Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands
  申请人：Cook, II James H.

  公开号：US20100099684A1

  公开（公告）日：2010-04-22

  The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands for the nicotinic α7 receptor and may be useful for the treatment of various disorders of the central nervous system, especially affective and neurodegenerative disorders.

  本公开提供公式I的化合物，包括其盐，以及使用这些化合物的组合物和方法。这些化合物是尼古丁α7受体的配体，可能对中枢神经系统的各种疾病，特别是情感和神经退行性疾病的治疗有用。